Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(4.40)
# 1,268
Out of 5,136 analysts
67
Total ratings
62.5%
Success rate
21.6%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFLY Butterfly Network | Reiterated: Buy | $15 | $5.71 | +162.70% | 2 | Oct 30, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $425 → $480 | $417.80 | +14.89% | 11 | Oct 30, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 → $27 | $18.65 | +44.77% | 4 | Sep 2, 2026 | |
| NTRA Natera | Reiterated: Buy | $300 → $360 | $288.48 | +24.79% | 9 | Aug 7, 2026 | |
| PODD Insulet | Reiterated: Buy | $180 | $145.29 | +23.89% | 6 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $40 → $54 | $59.12 | -8.66% | 9 | Aug 4, 2026 | |
| RGEN Repligen | Reiterated: Buy | $140 → $160 | $162.78 | -1.71% | 9 | Jul 6, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $118 → $90 | $92.21 | -2.40% | 6 | Jul 6, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $72.79 | -31.31% | 6 | May 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $81.61 | -16.68% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $90 | $144.03 | n/a | 4 | Oct 30, 2025 |
Butterfly Network
Oct 30, 2026
Reiterated: Buy
Price Target: $15
Current: $5.71
Upside: +162.70%
West Pharmaceutical Services
Oct 30, 2026
Reiterated: Buy
Price Target: $425 → $480
Current: $417.80
Upside: +14.89%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $20 → $27
Current: $18.65
Upside: +44.77%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $300 → $360
Current: $288.48
Upside: +24.79%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $180
Current: $145.29
Upside: +23.89%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: $40 → $54
Current: $59.12
Upside: -8.66%
Repligen
Jul 6, 2026
Reiterated: Buy
Price Target: $140 → $160
Current: $162.78
Upside: -1.71%
TransMedics Group
Jul 6, 2026
Reiterated: Buy
Price Target: $118 → $90
Current: $92.21
Upside: -2.40%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $72.79
Upside: -31.31%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $81.61
Upside: -16.68%
Oct 30, 2025
Reiterated: Buy
Price Target: $68 → $90
Current: $144.03
Upside: n/a